PBH - Prestige Consumer Healthcare Inc Stock Price, Fair Value and News

68.05USD-0.09 (-0.13%)Delayed

Market Summary

USD68.05-0.09

Delayed

-0.13%

PBH Stock Price

View Fullscreen

PBH RSI Chart

PBH Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

-41.88

Price/Sales (Trailing)

2.98

EV/EBITDA

1.5K

Price/Free Cashflow

14.56

PBH Price/Sales (Trailing)

PBH Profitability

Operating Margin

55.23%

EBT Margin

-8.28%

Return on Equity

-5.04%

Return on Assets

-2.42%

Free Cashflow Yield

6.87%

PBH Fundamentals

PBH Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

2.62%

Rev. Growth (Qtr)

-1.25%

PBH Earnings

Earnings (TTM)

-80.7M

Earnings Growth (Yr)

2.11%

Earnings Growth (Qtr)

-0.96%

Breaking Down PBH Revenue

Last 7 days

-1.6%

Last 30 days

-8.9%

Last 90 days

15.7%

Trailing 12 Months

9.2%

How does PBH drawdown profile look like?

PBH Financial Health

Current Ratio

3.09

Debt/Equity

0.75

Debt/Cashflow

0.2

PBH Investor Care

Buy Backs (1Y)

0.08%

Diluted EPS (TTM)

-1.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.1B	1.1B	1.1B	1.1B
2022	1.1B	1.1B	1.1B	1.1B
2021	943.4M	983.2M	1.0B	1.1B
2020	963.0M	960.3M	959.6M	956.8M
2019	975.8M	954.0M	952.7M	952.8M
2018	1.0B	1.0B	1.0B	990.7M
2017	882.1M	929.1M	972.0M	1.0B
2016	806.2M	823.7M	832.7M	849.2M
2015	714.6M	761.1M	785.8M	788.4M
2014	597.4M	600.6M	614.9M	667.6M
2013	623.6M	619.1M	624.2M	608.8M
2012	441.1M	492.8M	549.1M	603.1M
2011	333.7M	357.8M	385.0M	400.7M
2010	292.6M	302.9M	313.2M	323.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Prestige Consumer Healthcare Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	fritz mary beth	acquired	6,906	40.1556	172	svp quality & regulatory
Mar 01, 2024	fritz mary beth	sold	-12,111	70.4172	-172	svp quality & regulatory
Feb 28, 2024	fritz mary beth	sold	-46,536	70.2968	-662	svp quality & regulatory
Feb 28, 2024	fritz mary beth	acquired	26,779	40.452	662	svp quality & regulatory
Feb 27, 2024	fritz mary beth	acquired	57.18	57.18	1.00	svp quality & regulatory
Feb 27, 2024	fritz mary beth	sold	-70.00	70.00	-1.00	svp quality & regulatory
Feb 26, 2024	fritz mary beth	sold	-681,597	70.4347	-9,677	svp quality & regulatory
Feb 26, 2024	fritz mary beth	acquired	432,343	44.6774	9,677	svp quality & regulatory
Feb 23, 2024	fritz mary beth	acquired	1,022	44.4487	23.00	svp quality & regulatory
Feb 23, 2024	fritz mary beth	sold	-1,610	70.00	-23.00	svp quality & regulatory

Which funds bought or sold PBH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 15, 2024	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	reduced	-0.34	81,943	534,114	-%
Apr 15, 2024	Legato Capital Management LLC	added	1.98	462,014	2,676,160	0.32%
Apr 15, 2024	EXCHANGE TRADED CONCEPTS, LLC	added	0.54	236,902	1,472,750	0.04%
Apr 12, 2024	HARBOR INVESTMENT ADVISORY, LLC	new	-	1,669	1,669	-%
Apr 12, 2024	WASHINGTON CAPITAL MANAGEMENT, INC	unchanged	-	96,390	616,760	0.50%
Apr 12, 2024	Financial Synergies Wealth Advisors, Inc.	unchanged	-	150	1,089	-%
Apr 12, 2024	AdvisorNet Financial, Inc	reduced	-14.29	14.00	871	-%
Apr 12, 2024	MILLER HOWARD INVESTMENTS INC /NY	added	0.62	89,027	551,238	0.02%
Apr 11, 2024	CONGRESS ASSET MANAGEMENT CO /MA	added	12.48	13,852,700	55,436,800	0.40%
Apr 09, 2024	Rise Advisors, LLC	new	-	11,247	11,247	0.01%

Are Funds Buying or Selling PBH?

Are funds buying PBH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PBH

No. of Funds

Unveiling Prestige Consumer Healthcare Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	macquarie group ltd	6.17%	3,062,581	SC 13G
Feb 14, 2024	ariel investments, llc	5.2%	2,555,777	SC 13G
Feb 13, 2024	vanguard group inc	11.60%	5,756,138	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	6.9%	3,434,500	SC 13G/A
Jan 19, 2024	blackrock inc.	18.3%	9,067,957	SC 13G/A
Feb 10, 2023	dimensional fund advisors lp	7.4%	3,674,930	SC 13G/A
Feb 09, 2023	vanguard group inc	11.61%	5,748,791	SC 13G/A
Jan 23, 2023	blackrock inc.	19.0%	9,407,577	SC 13G/A
Feb 08, 2022	dimensional fund advisors lp	6.9%	3,435,736	SC 13G/A
Jan 28, 2022	blackrock inc.	16.2%	8,111,381	SC 13G/A

Recent SEC filings of Prestige Consumer Healthcare Inc

View All Filings

Date Filed	Form Type	Document
Mar 05, 2024	4	Insider Trading
Mar 01, 2024	144	Notice of Insider Sale Intent
Feb 29, 2024	4	Insider Trading
Feb 28, 2024	144	Notice of Insider Sale Intent
Feb 27, 2024	144	Notice of Insider Sale Intent
Feb 27, 2024	4	Insider Trading
Feb 26, 2024	144	Notice of Insider Sale Intent
Feb 23, 2024	144	Notice of Insider Sale Intent
Feb 20, 2024	4	Insider Trading
Feb 16, 2024	4	Insider Trading

Peers (Alternatives to Prestige Consumer Healthcare Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	348.0B	85.2B	-8.67%	-12.80%	9.9	4.09	6.46%	95.94%
MRK	316.7B	60.1B	2.91%	8.74%	867.76	5.27	1.40%	-97.49%
PFE	145.1B	46.5B	-8.05%	-37.62%	-104.48	3.12	42.59%	-114.62%
AMGN	142.4B	28.2B	-1.17%	7.12%	21.2	5.05	7.09%	2.52%
GILD	83.9B	27.1B	-8.64%	-19.50%	14.81	3.09	-0.60%	23.36%
TEVA	14.7B	15.8B	-2.46%	54.12%	-25.47	0.93	6.17%	76.47%
MID-CAP
PRGO	4.1B	4.7B	-1.38%	-18.66%	-319.58	0.87	4.58%	90.97%
ALKS	4.0B	1.7B	-17.22%	-19.16%	11.18	2.39	49.61%	324.78%
BHC	3.2B	8.8B	-5.00%	14.25%	-5.39	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-4.97%	-2.50%	14.31	3.05	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	6.36%	-26.40%	-4.05	1.92	24.65%	80.36%
TXMD	22.1M	1.3M	-20.00%	-47.68%	-2.15	0.38	-98.14%	-109.18%
ACRX	17.3M	-	-11.30%	34.21%	-0.94	0.22	2882.68%	-138.52%
AGRX	1.2M	19.6M	-27.78%	-94.56%	-0.08	0.06	80.00%	43.08%
ACOR	496.8K	117.6M	-96.45%	-95.94%	0	0	-0.79%	-283.60%

Prestige Consumer Healthcare Inc News

Latest updates

Prestige Consumer Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-1.2%	283	286	279	286	276	289	277	267	274	276	269	238	239	237	229	251	242	238	232	241	241
Cost Of Revenue	-1.2%	125	126	125	132	125	128	117	118	119	119	110	101	100	100	96.00	107	104	101	98.00	103	102
Gross Profit	-1.3%	158	160	155	154	150	161	160	149	155	158	159	137	139	138	134	144	137	137	134	138	139
Operating Expenses	-0.9%	71.00	72.00	69.00	435	63.00	77.00	73.00	71.00	72.00	79.00	68.00	66.00	65.00	65.00	54.00	70.00	61.00	67.00	63.00	292	62.00
S&GA Expenses	0.0%	26.00	26.00	28.00	28.00	27.00	26.00	27.00	27.00	26.00	32.00	22.00	21.00	21.00	20.00	20.00	24.00	21.00	23.00	22.00	21.00	20.00
EBITDA Margin	-14.9%	0.00*	0.00*	0.00*	0.01*	0.32*	0.32*	0.33*	0.33*	0.31*	0.32*	0.33*	0.34*	-	-	-	-	-	-	-	-	-
Interest Expenses	5.9%	-16.57	-17.61	-17.72	119	-17.92	-16.98	-15.29	113	-16.92	-16.31	-15.08	146	-20.14	-21.27	-21.94	145	-24.27	-24.48	25.00	26.00	26.00
Income Taxes	-1.9%	17.00	17.00	15.00	-58.97	16.00	16.00	16.00	9.00	15.00	14.00	19.00	5.00	13.00	7.00	14.00	13.00	12.00	11.00	12.00	-39.76	13.00
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	59.00	-	-	-	51.00	51.00	44.00	46.00	-179	51.00
EBT Margin	0.6%	-0.08*	-0.08*	-0.08*	-0.08*	0.24*	0.24*	0.24*	0.24*	0.19*	0.20*	0.21*	0.22*	-	-	-	-	-	-	-	-	-
Net Income	-1.0%	53.00	54.00	53.00	-240	52.00	51.00	55.00	52.00	50.00	45.00	58.00	36.00	41.00	45.00	44.00	37.00	38.00	33.00	34.00	-139	38.00
Net Income Margin	2.0%	-0.07*	-0.07*	-0.07*	-0.07*	0.19*	0.19*	0.19*	0.19*	0.18*	0.18*	0.18*	0.17*	-	-	-	-	-	-	-	-	-
Free Cashflow	16.7%	69.00	60.00	47.00	56.00	53.00	55.00	57.00	60.00	64.00	58.00	68.00	54.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	0.2%	3,340	3,333	3,346	3,354	3,750	3,679	3,682	3,671	3,659	3,676	3,559	3,429	3,469	3,434	3,450	3,514	3,464	3,465	3,461	3,441	3,668
Current Assets	1.4%	394	388	392	392	409	337	325	293	275	305	409	270	301	270	296	366	300	305	311	301	293
Cash Equivalents	5.9%	64.00	60.00	55.00	58.00	86.00	42.00	36.00	27.00	21.00	43.00	164	32.00	62.00	27.00	58.00	95.00	29.00	28.00	29.00	28.00	25.00
Inventory	-7.8%	149	161	170	162	159	141	134	120	106	108	106	115	117	114	117	116	121	126	129	120	120
Net PPE	-0.5%	70.00	71.00	70.00	70.00	70.00	70.00	70.00	71.00	70.00	70.00	70.00	70.00	69.00	65.00	58.00	56.00	53.00	53.00	51.00	51.00	52.00
Goodwill	0.2%	528	527	527	528	577	576	577	579	579	579	1.00	578	580	578	577	575	578	578	578	579	612
Liabilities	-3.2%	1,739	1,797	1,865	1,907	2,063	2,059	2,097	2,093	2,141	2,214	2,143	2,071	2,146	2,156	2,223	2,343	2,308	2,352	2,359	2,345	2,435
Current Liabilities	-1.7%	127	130	147	161	160	152	155	143	135	149	125	122	126	136	132	150	149	147	143	127	129
Long Term Debt	-5.0%	1,199	1,263	1,317	1,346	1,424	1,438	1,472	1,477	1,530	1,593	1,545	1,480	1,549	1,548	1,621	1,730	1,701	1,754	1,779	1,799	1,842
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	6.00	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	1,346	-	-	-	1,477	-	-	1,545	1,480	1,549	1,548	1,621	1,730	1,701	1,754	1,779	1,799	1,842
Shareholder's Equity	4.2%	1,601	1,536	1,480	1,447	1,687	1,620	1,585	1,578	1,518	1,462	1,416	1,358	1,323	1,278	1,227	1,171	1,156	1,113	1,102	1,096	1,233
Retained Earnings	4.3%	1,292	1,239	1,185	1,132	1,372	1,320	1,269	1,214	1,162	1,112	1,067	1,009	973	932	888	844	807	769	736	702	841
Additional Paid-In Capital	0.7%	556	552	547	535	533	524	521	516	513	507	504	500	495	494	491	488	486	484	481	479	478
Shares Outstanding	0.0%	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	2,452	-	-	-	2,799	-	-	-	1,821	-	-	-	1,738	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	14.4%	71,472	62,460	48,087	58,987	54,942	57,540	58,247	63,126	66,297	61,194	69,305	59,087	49,227	52,139	75,154	56,126	57,998	50,223	52,777	50,847	43,330
Share Based Compensation	-33.6%	2,449	3,688	4,146	2,649	2,433	3,466	3,857	1,708	2,234	3,219	1,878	2,599	1,588	2,892	1,464	1,962	1,780	2,521	1,381	1,278	1,832
Cashflow From Investing	-53.2%	-4,496	-2,934	2,323	-6,358	-1,803	-2,376	-1,047	-3,293	-20,229	-231,666	-1,323	-4,896	-5,728	-9,066	-2,553	-8,265	-2,483	-3,866	-1,956	-3,341	-2,065
Cashflow From Financing	-21.1%	-64,843	-53,549	-54,179	-80,495	-10,021	-47,956	-47,374	-54,115	-67,638	50,534	63,650	-83,709	-9,044	-75,304	-111,362	20,557	-55,676	-47,022	-49,290	-45,000	-53,097
Buy Backs	-	-	-	25,000	-	-	12,273	37,727	-	-	-	-	1,993	8,877	997	-	6,745	-	21,210	28,766	-	-

PBH Income Statement

2023-12-31

Condensed Consolidated Statements of Income and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Revenues
Total revenues	$ 282,741	$ 275,524	$ 848,366	$ 841,856
Cost of Sales
Cost of sales excluding depreciation	122,794	123,251	369,772	364,631
Cost of sales depreciation	2,009	1,871	5,963	5,695
Cost of sales	124,803	125,122	375,735	370,326
Gross profit	157,938	150,402	472,631	471,530
Operating Expenses
Advertising and marketing	39,466	30,423	115,799	114,193
General and administrative	26,003	26,536	79,687	79,688
Depreciation and amortization	5,637	6,259	16,869	19,067
Total operating expenses	71,106	63,218	212,355	212,948
Operating income	86,832	87,184	260,276	258,582
Other expense
Interest expense, net	16,575	17,917	51,900	50,188
Other expense (income), net	682	1,150	(327)	2,787
Total other expense, net	17,257	19,067	51,573	52,975
Income before income taxes	69,575	68,117	208,703	205,607
Provision for income taxes	16,529	16,166	48,822	47,361
Net income	$ 53,046	$ 51,951	$ 159,881	$ 158,246
Earnings per share:
Basic (in USD per share)	$ 1.07	$ 1.05	$ 3.21	$ 3.17
Diluted (in USD per share)	$ 1.06	$ 1.04	$ 3.19	$ 3.14
Weighted average shares outstanding:
Basic (in shares)	49,740	49,693	49,731	49,919
Diluted (in shares)	50,125	50,186	50,134	50,392
Comprehensive income, net of tax:
Currency translation adjustments	$ 7,465	$ 6,970	$ 3,035	$ (9,667)
Net loss on termination of pension plan	0	0	0	(790)
Total other comprehensive income (loss)	7,465	6,970	3,035	(10,457)
Comprehensive income	60,511	58,921	162,916	147,789
Net sales
Revenues
Total revenues	282,715	275,495	848,321	841,783
Other revenues
Revenues
Total revenues	$ 26	$ 29	$ 45	$ 73

PBH Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets
Cash and cash equivalents	$ 63,615	$ 58,489
Accounts receivable, net of allowance of $18,710 and $20,205, respectively	174,288	167,016
Inventories	148,637	162,121
Prepaid expenses and other current assets	7,246	4,117
Total current assets	393,786	391,743
Property, plant and equipment, net	70,356	70,412
Operating lease right-of-use assets	10,695	14,923
Finance lease right-of-use assets, net	2,206	4,200
Goodwill	527,878	527,553
Intangible assets, net	2,328,529	2,341,893
Other long-term assets	6,303	3,005
Total Assets	3,339,753	3,353,729
Current liabilities
Accounts payable	39,339	62,743
Accrued interest payable	15,197	15,688
Operating lease liabilities, current portion	5,650	6,926
Finance lease liabilities, current portion	2,188	2,834
Other accrued liabilities	65,063	72,524
Total current liabilities	127,437	160,715
Long-term debt, net	1,199,340	1,345,788
Deferred income tax liabilities	397,147	380,434
Long-term operating lease liabilities, net of current portion	6,138	9,876
Long-term finance lease liabilities, net of current portion	195	1,667
Other long-term liabilities	8,919	8,165
Total Liabilities	1,739,176	1,906,645
Commitments and Contingencies — Note 14
Stockholders' Equity
Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None	0	0
Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 55,291 shares at September 30, 2023 and 54,857 shares at March 31, 2023	553	548
Additional paid-in capital	556,452	535,356
Treasury stock, at cost - 5,680 shares at December 31, 2023 and 5,165 shares at March 31, 2023	(219,638)	(189,114)
Accumulated other comprehensive loss, net of tax	(28,529)	(31,564)
Retained earnings	1,291,739	1,131,858
Total Stockholders' Equity	1,600,577	1,447,084
Total Liabilities and Stockholders' Equity	$ 3,339,753	$ 3,353,729

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

CEO	Mr. Ronald M. Lombardi
WEBSITE	prestigebrands.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	560

Prestige Consumer Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Prestige Consumer Healthcare Inc? What does PBH stand for in stocks?

PBH is the stock ticker symbol of Prestige Consumer Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Prestige Consumer Healthcare Inc (PBH)?

As of Tue Apr 16 2024, market cap of Prestige Consumer Healthcare Inc is 3.38 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers. The fair value of Prestige Consumer Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Prestige Consumer Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PBH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Prestige Consumer Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether PBH is over valued or under valued. Whether Prestige Consumer Healthcare Inc is cheap or expensive depends on the assumptions which impact Prestige Consumer Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PBH.

What is Prestige Consumer Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, PBH's PE ratio (Price to Earnings) is -41.88 and Price to Sales (PS) ratio is 2.98. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PBH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Prestige Consumer Healthcare Inc's stock?

In the past 10 years, Prestige Consumer Healthcare Inc has provided 0.096 (multiply by 100 for percentage) rate of return.